TPG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
TPG Inc is not a strong buy for a beginner, long-term investor at this moment. Despite strong financial growth in the latest quarter and positive analyst sentiment, the technical indicators are bearish, options data suggests a cautious sentiment, and the stock trend indicates potential short-term downside. Given the user's impatience and unwillingness to wait for optimal entry points, it is better to hold off on investing in TPG at this time.
The technical indicators for TPG are bearish. The MACD is negative and contracting, RSI is neutral at 37.656, and moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). Key support lies at $42.297, with resistance at $49.578. The stock is trading below its pivot level of $45.938, suggesting weakness.
Strong financial performance in Q4 2025, with revenue up 38.40% YoY and net income up 1726.80% YoY.
Analysts maintain a generally positive outlook, with multiple Buy and Outperform ratings and price targets ranging from $49 to $
The company is diversifying its business and expanding its platform, which analysts view as a positive long-term strategy.
Bearish technical indicators and a weak short-term stock trend, with an 80% chance of a -0.64% decline in the next week and -3.43% in the next month.
Concerns in the private credit market, which could indirectly impact TPG's business.
No significant insider or hedge fund activity, indicating a lack of strong conviction from key stakeholders.
In Q4 2025, TPG reported impressive financial growth. Revenue increased by 38.40% YoY to $1.49 billion, net income surged by 1726.80% YoY to $65.86 million, and EPS grew by 866.67% YoY to $0.29. However, gross margin remained unchanged at 0%.
Analysts are generally positive on TPG. RBC Capital initiated coverage with an Outperform rating and a $59 price target, citing an attractive entry point after a selloff. BofA, UBS, and Barclays lowered price targets but maintained Buy or Overweight ratings, citing strong earnings growth potential and a robust fundraising outlook. However, TD Cowen downgraded the stock to Hold with a $49 price target, reflecting cautious sentiment in the asset manager space.
